期刊文献+

纳米银涂层输尿管支架抗菌效果的体内外实验研究 被引量:3

Experimental studies of antibacterial effect of ureteral stent coated with nano-silver in vitro and in vivo
下载PDF
导出
摘要 目的 观察纳米银表面涂层输尿管支架的体内、外抗菌性能.方法 根据纳米银颗粒直径分组(A组直径<20 nm,B组直径20~40 nm,c组直径>40 nm,D组为未涂层的普通胚管),试菌种选用大肠杆菌和金黄色葡萄球菌,应用体外抗菌环实验测量输尿管支架周围抑菌圈直径的大小,观察纳米银输尿管支架对细菌总DNA的影响,将纳米银输尿管支架植入家兔体内后分期检测尿白细胞量.结果 A、B、C三组均可见抗菌环出现,D组无抗菌环产生.大肠杆菌组间:F =784.93,P<0.05,各组间比较均P<0.05;金黄色葡萄球菌组间:F=545.8979,p <0.05,各组间比较均P<0.05.经纳米银输尿管支架处理和未处理的大肠杆菌总DNA电泳后显示处理组DNA量减少,并可观察到部分降解DNA的明亮区域.两组输尿管支架植入动物体内试验显示纳米银涂层组尿白细胞阳性率低于对照组(jP<0.05).结论 纳米银涂层输尿管支架具有良好的表面效应及理想的抗菌效果. [Objective ] To investigate the antibaeterial property of ureteral stent coated with nano-silver in vitro and in vivo. [Methods ] Ureteral stents were divided into groups according to the diameter of silver grains (group A: 〈20 nm, group B: 20-40 nm, group C: 〉40 nm, group D: non-coating ureteral Stents). Antibacterial circle diameter around the ureteral stents was measured by using escheriehia eoli and staphylococcus aureus as the experimental bacteria. The effect of ureteral stent coated with nano-silver on the total microbial DNA was observed. Urinary leukocyte count of rabbits which were treated with ureteral stents coated with nanometer-silver was detected regu- larly. [Results] Antihacterial circles were found in the group A, B and C, which was no found in the group D. There were statistical difference among the groups of escherichia coli (F =784.93, P 〈0.05) and that of staphylococcus au- reus(F =545.8979, P 〈0.05). The gel electrophoresis result of total DNA indicated that the DNA amount of nano-sil- ver coated group was less than that of control group. In vivo studies show that the positive rate of urinary leukocyte in the nano-silver treatment group was lower than that in the control group. [Conclusions] Ureteral stent coated with nano-silver have good surface effect amt antibacterial effeet.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2013年第27期26-29,共4页 China Journal of Modern Medicine
关键词 纳米银涂层 输尿管支架 抗菌性 nano-silver coating ureteral stents antibacterial capability
  • 相关文献

参考文献1

二级参考文献12

  • 1BERGER TJ, SPADARO JA, CHAPIN SE, et al. Electrically generated silver ions: quantitative effects on bacterial and mammalian cells[J]. Anti Microb Agents, 1976, 9(2):357--358.
  • 2ZHAO GJ, STEVENS SE. Multiple parameters for comprehensive evaluation of the susceptibility of Escherichia coll to the silver ion[J]. Bio Metals, 1998, 11:27--32.
  • 3SAMBROOK J, FRITSCH EF, MANISTIS T. Molecular cloning: a laboratory manual [M]. 3rd ed, New York: Cold Spring Harbor Laboratory Press, 2001.
  • 4SONDI I, SALOPEKAI-SONDI B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria[J]. Journal of Colloid and Interface Science, 2004, 275:177--182.
  • 5HAMOUDA T, BAKER JR. Antimicrobial mechanism of action of surfactant lipid preparations in enteric gram-negative bacilli[J]. Journal of Applied Microbiology, 2000, 89 : 397-- 403.
  • 6STOIMENOV PK, KLINGER RL, MARCHIN GL, et al. Metal oxide nanoparticles as bactericidal agents[J]. Langmuir, 2002, 18:6679--6686.
  • 7FENG QL, WU J, CHEN GQ, et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcusaureus[J]. J Biomed Mater Res, 2000, 52:662--668.
  • 8AMRO NA, KOTRA LP, High-resolution atomic force WADU-MESTHRIGE K, et al. microscopy studies of the escherichia eoli outer membrane: structural basis for permeability [J]. Langmuir, 2000, 16:2789--2796.
  • 9刘康时,江显异,赵英.银系无机抗菌剂作用机理的研究进展[J].佛山陶瓷,2001,11(11):1-5. 被引量:37
  • 10林爱红,秦彦珉,饶健,黄惠英.纳米抗菌剂抑菌杀菌性能研究[J].实用预防医学,2003,10(2):168-170. 被引量:45

共引文献60

同被引文献65

  • 1Venkatesan N, Shroff S, Jayachandran K, et al. Polymers as ureteral stents [J]. J Endourol, 2010, 24(2): 191-198.
  • 2Chew BH, Paterson RF, Clinkscalcs KW, et al. In vivo evaluation of the third generation biodegradable stent: a novel approach to avoid- ing the forgotten stent syndrome [J]. J Urol, 2013, 189(2): 719-725.
  • 3Sountoulidcs P, Kaplan A, Kaufmann OG, et al. Current status of metal stents for managing malignant urcteric obstruction [J]. BJU Int, 2010, 105(8): 1066-1072.
  • 4Bourdoumis A, Kachrilas S, Kapoor S, et al. The use ofa thermoex- pandable metal alloy stent in the minimally invasive management of retropcritoneal fibrosis: a single center experience from the Unit- ed Kingdom [J]. J Endourol, 2014, 28(1): 96-99.
  • 5Sofia F, MorciUo E, Pamploua M, et al. Evaluation in an animal model of a hybrid covered metallic ureteral stem: a new design [J]. Urology, 2013, 81(2): 458-463.
  • 6Cauda F, Cauda V, Fiori C, et at.. Heparin coating on ureteral Double J stents prevents encrustations: an in vivo case study [J]. J Endourol, 2008, 22(3): 465-472.
  • 7Chew BH, Davoudi H, Li J, et al. An in vivo porcine evaluation of the safety, bioavailability, and tissue penetration of a ketorolac drug-eluting ureteral stent designed to improve comfort [J]. J En- dourol, 2010, 24(6): 1023-1029.
  • 8Elayarajah, Rajendran R, Venkatrajah, et al. Biodegradable tocopher- ol acetate as a drug carrier to prevent ureteral stent-associated infec- tion [J]. Pak J Biol Sci, 2011, 14(5): 336-343.
  • 9Kallidonis P, Kitrou P, Karnabatidis D, et al. Evaluation of zotaroli- mus-eluting metal stent in animal ureters [J]. J Endourol, 2011, 25 (10): 1661-1667.
  • 10Mendez-Probst CE, Goneau LW, MaeDouald KW, et al. The use of triclosan ehting stents effectively reduces ureteral stent symptoms: a prospective randomized trial [J]. BJU Int, 2012, 110(5): 749-754.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部